What Do You Do When Your Chemotherapy Stops Working?

Every day, thousands of cancer patients are either recommended chemotherapy or told that their chemotherapy didn’t work. For the last 15 years, and after helping thousands of patients, we have made it our mission to be able to bring the latest technology and the best of targeted cancer treatments from around the world to our patients. Our motto is to go above and beyond chemotherapy. We don’t just provide what the pharmaceuticals companies recommend. This is because at the end of the day, we believe every patient’s life is precious and we as physicians have a responsibility to provide the best personalized and targeted customized care for our patients.

What makes Envita so special is that we offer a unique and comprehensive approach called Unipathic Medicine. This type of medicine employs the best of personalized and targeted cancer technologies from around the world, and this is one of the many reasons that over 90% of our patients travel outside of their home state to come to our facility. Our typical patients are ones who failed conventional means of treatment (recommended drugs or radiation), or patients that are looking for a different personalized approach.

At Envita, we use an approach that utilizes targeted biomarkers and molecular targets that are specific to each person’s genomics. For those who don’t know, biomarkers and molecular targets contain information that can be gathered from a person’s cancer cells and then used to tell what chemotherapeutic agents may work best for that specific patient. These biomarkers can also help locate natural phytotherapeutics, which aid in personalizing a treatment program. With our cutting edge technology, we are able to take the guess work out of a patient’s program and look not at the “Pharma only recommended drug” for a type of cancer but at what drug and natural agents respond best to a patient’s individual cancer cells. We call this treatment process, Genetically Targeted Fractionated Chemotherapy, or GTFC for short.

GTFC is a new treatment that was been successfully used for several years and is currently offered at Envita. This targeted therapy is being called the “real second opinion for cancer patients” by our doctors. GTFC is a form of low dose, fractionated chemotherapy that can hit up to 7-10 genetic markers, something traditional chemotherapy cannot do. GTFC also ensures that the majority of our patients experience minimal side effects due to the utilization of metronomic/low dosing. Here is how it works: Genetic information is collected real time through a blood test, not simply from a biopsy. This means that the information that the doctors are looking at shows what the patient’s cancer genetics are most likely going to respond to today, not 6 months ago when the biopsy was originally performed. The real key and revolutionary approach here lies not only with the best drug options but also with the best natural phytotherapeutics to help enhance overall care. Targeted natural therapies are oftentimes shown to help and enhance patient care alongside chemotherapeutic targets. The best part is that they are often times non-toxic!

Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from person to person and should not be expected.

Keep in mind that GTFC is only one of the powerful options that Envita has to offer. Envita is renowned for its work in personalized immunotherapy with a focus on micro-metastasis (the spread of cancer cells) as well as DNA mutation and causative factors that guide cancer.

The time to revolutionize your cancer treatment is now! Contact one of our patient care educators today, to see if we can improve your cancer treatment plan. We are looking forward to hearing from you, and we wish you the best of health!

Recommended Videos